EBE-A22 60181 also known as FI-3542

also known as FI-3542

revealing a role for TGFβ signaling mechanism as a repressor of cardiomyocyte fate

5-tetramine hydrochloride

a single dose of 200 or 400 mg of fleroxacin is inadequate therapy for chancroid

Hazarika N

EBE-A22 60181 also known as FI-3542EBE A22 is a derivative of PD 153035. EBE A22, has no effect on EGF R TK but maintains a high cytotoxic profile. EBE A22 binds to DNA and behave as typical intercalating agents. EBE A22 unwinds supercoiled plasmid, stabilizes duplex DNA against heat denaturation, and produces negative CD and ELD signals, as expected for an intercalating agent. EBE A22, but not PD153035, interacts preferentially with GC rich sequences and discriminates against